妊娠哺乳相关性骨质疏松症的现状及研究进展OA
Current status and research progress of pregnancy-and lactation-associated osteoporosis
妊娠哺乳相关性骨质疏松症(PLO)虽发病率较低,但其实际患病率常被低估,病因尚不明确,临床上亟需系统性认识.本文基于现有PLO相关研究,归纳了其流行病学特征、危险因素及可能机制、骨代谢指标变化、骨损害特征及诊治进展,并对PLO患者哺乳期的用药规范提出建议,以期为临床医师管理PLO提供可行的诊疗路径与参考方案.
Pregnancy-and lactation-associated osteoporosis(PLO)is a rare but likely underrecognized disor-der characterized by fragility fractures occurring during late pregnancy or the postpartum lactation period.Although its true prevalence is probably underestimated,the etiology and pathogenesis of PLO remain incompletely understood,highlighting the need for greater clinical awareness and a more systematic understanding of this condition.Based on current evidence,this review summarizes the epidemiological characteristics,risk factors,and potential pathogenic mechanisms of PLO,as well as alterations in bone turnover markers,patterns of skeletal involvement,and recent advances in diagnosis and man-agement.In addition,recommendations regarding pharmacological management during the lactation period are discussed,with particular emphasis on medication safety and standardized therapeutic strategies.This review aims to provide clini-cians with a practical framework for the diagnosis,treatment,and long-term management of patients with PLO.
郑柯宏;李佳
广东药科大学(广东 广州 510006)中国人民解放军南部战区总医院内分泌科(广东 广州 510010)
医药卫生
妊娠哺乳骨质疏松症骨转化诊疗用药安全
pregnancylactationosteoporosisbone turnoverdiagnosis and treatmentmedication safety
《广东医学》 2026 (7)
978-983,6
国家重点研发计划(2021YFC2501701)
评论